US 10822599
Compositions for linking DNA-binding domains and cleavage domains
granted A61PA61P13/12A61P19/00
Quick answer
US patent 10822599 (Compositions for linking DNA-binding domains and cleavage domains) held by Sangamo Therapeutics, Inc. expires Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sangamo Therapeutics, Inc.
- Grant date
- Tue Nov 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61P, A61P13/12, A61P19/00, A61P25/00, A61P25/14